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ABSTRACT
The present study was undertaken to examine possible aluminum (Al)
accumulation in the brain of rats and to investigate whether subchronic
exposure to the metal leads to behavioral and neurophysiological changes
in both treated and control groups. Each of the groups was consisted of 10
animals. Aluminum chloride (AlCl3) at a low (50 mg/kg/d) or high (200
mg/kg/d) dose was applied to male Wistar rats by gavage for 8 wk. Al-free
water by gavage was given to the control group throughout the experiment.
Behavioral effects were evaluated by open-field (OF) motor activity and by
acoustic startle response (ASR). Electrophysiological examination was done
by recording spontaneous activity and sensory-evoked potentials from the
visual, somatosensory, as well as auditory cortex. The Al content of each
whole brain was determined by electrothermal atomic absorption spec-
trophotometry. Subchronic Al exposure slightly caused some changes in the
evoked potentials and electrocorticograms and in the OF and ASR per-
formance, but these results were not statistically significant. The brain Al
levels of the control and the low and high dose of Al-exposed groups were
measured as 0.717±0.208 µg/g (wet weight), 0.963±0.491 µg/g (wet weight)
and 1.816±1.157 µg/g (wet weight), respectively.
Index Entries: Aluminum; subchronic intake; rat; behavior; electro-
physiology.
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INTRODUCTION
Aluminum (Al) is an element ubiquitously found in the Earth’s crust.
It is present in numerous sources, including water, air, food, drugs, cos-
metics (including deodorants), and household materials (including
kitchen tools, paper towels, etc.). Human exposure to Al is thus inevitable
but neither cases of Al deficiency nor any physiological function for Al
have been described as yet (1–3).
Aluminum toxicity was first recognized in 1972 and its association
with a neurological syndrome in patients on prolonged hemodialysis
reported. This syndrome included progressive dementia, speech difficul-
ties, facial grimacing, motor abnormalities, and electroencephalographic
changes. Since then, further neurological syndromes have been attributed
to aluminum (4).
There is much evidence on mechanisms by which aluminum affects
brain tissue, including protein synthesis, axonal transport, and neuro-
transmitter-related events, such as disruption in intraneuronal calcium
homeostasis, inhibition of catechol-O-methyl transferase, ceruloplasmin,
cholinesterase, choline acetyltransferase, glycerokinase, Mg-adenosine
triphosphatase, and calmodulin, and activation of adenylate cyclase and d-
aminolevulinic acid dehydratase. Al combines with adenosine triphos-
phate (ATP) to form an Al–ATP complex, which is a competitive inhibitor
of hexokinase and dihydropteridine reductase (4–11).
Aluminum can be eliminated extremely slow from the brain and,
therefore, it easily accumulates in the brain. It was shown that, in rats, Al
also causes an increase in the permeability of the blood–brain barrier to
certain small peptides like endorphin (7). An increase in the blood–brain
barrier permeability could thus lead to alterations in brain biochemistry,
resulting in functional and behavioral abnormalities ultimately manifest-
ing in dementia or other central nervous system (CNS) disorders. As a
result of increasing permeability, the CNS also becomes vulnerable to the
hazardous effects of other xenobiotics (7,11,12).
It is suggested that the distribution of Al depends on the animal
species in question, the route of administration, and the chemical form of
aluminum administered (3,9,13). There is much evidence that Al is neuro-
toxic in experimental animals, although there is a wide variation among
species (10,13–15). Rabbits, cats, and mice are generally accepted as more
susceptible species to Al. Its toxicity has been characterized by progressive
neurological impairment, resulting in death with status epilepticus in
these species. It was observed that oral and parenteral, including intracra-
nial, Al administration to the animals can result in impaired learning,
memory retention, and motor coordination (3,10,14,15). Behavioral impair-
ment has been observed in the absence of overt encephalopathy or neuro-
histopathology in experimental animals exposed to soluble aluminum
salts in the diet or drinking water at doses of 50 mg Al/kg body weight per
day or more (3,16).
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Despite using aluminum exposure as an animal model for the study
of epilepsy, information processing, cognitive dysfunction, and motor neu-
ron disease, there is no extensive study on the evaluation of its effects on
electrophysiological parameters in less susceptible animals to Al such as
monkey, rats, and so forth (3,17,18). Therefore, the main goal of the pres-
ent study was to investigate the accumulation of Al in rat brain by means
of graphite furnace–atomic absorption spectrophotometry and to assess
the neurotoxicity of Al by examining behavioral and electrophysiological
methods at the same time.
MATERIALS AND METHODS
Experimental Design
Aluminum chloride (AlCl3, purity 99.5%; Reanal, Hungary) was made
up to treatment solution by dissolving in distilled water. Thirty male Wis-
tar rats (body weight ranged from 240 to 270 g) were obtained from
Research Institute of Laboratory Animals (Gödöllö, Hungary). During the
treatment period, the rats were housed in an animal room, five in a cage,
at 22–24°C and 65% humidity with a 12 : 12-h light–dark cycle, and all tests
took place during the light period. The rats had access to food and water
ad libitum. The animals were divided into three groups: group I (n=10)
was treated with distilled water as a control group, whereas group II
(n=10) and group III (n=10) were treated with aluminum at 50 mg/kg
body wt. and 200 mg/kg body wt. concentration of AlCl3, respectively.
Treatments were applied by gavage for 8 wk on a 5 d per week schedule.
Changes in the body weights of the animals were observed once a week.
Behavioral Tests
Motility and spontaneous exploration was investigated in an auto-
matic open field (OF, 40×40×40 cm; ACTIFRAME [Gerb Electronic, Berlin,
Germany]). The rats were put one by one into the OF for a 10-min session
in the second and eighth weeks of the treatment. Horizontal, vertical, as
well as stationary movements and speed of the movements were detected
by infrared sensors. Illumination of the OF floor was 10 lx and 30 dB white
background noise was applied.
Auditory startle response (ASR) and the “prepulse inhibition” were
measured subsequently by using of the Responder (Columbus Instruments,
Ohio, USA) equipment. The parameters were 5000 Hz, 110 dB, and 200 ms
for the eliciting stimulus, and 1000 Hz, 50 dB, and 500 ms for the prestimu-
lus. Ten stimuli were applied per session in a random sequence with inter-
vals between 10 and 15 s. Prestimulus was applied 200 ms before the
eliciting stimulus. The whole-body motor response was detected by a force-
measuring platform and crossing of the 50-g threshold was accepted as pos-
itive response. Latency, peak time, and peak amplitude were measured.
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Evaluation of Electrophysiological Test Parameters 
and Relative Tissue Weights
After the behavioral investigations, electrophysiological tests were
done. Spontaneous and stimulus-evoked cortical activity was recorded
from the animals in acute preparation. The animal was anesthetized with
1000 mg/kg, ip urethane and placed in a stereotaxic frame. The left hemi-
sphere was exposed by opening the skull and ball-tipped silver wire elec-
trodes were placed on the primary somatosensory (Part1), visual (OclB),
and auditory (Tel) cortical areas. Following a recovery of approx 30 min,
simultaneous electrocorticogram (ECoG) was recorded from these points
for 5 min. From the same locations, sensory-evoked potentials were sub-
sequently recorded. Somatosensory stimulation was done by a pair of nee-
dles delivering electric shocks (1 Hz, 3–4 V, 0.2 ms) to the whiskery part of
the skin. For visual stimulation, flashes (1 Hz, 60 lx) of a flashbulb were
directed to the contralateral eye via an optical conductor.
The ECoG analysis yielded the main frequency, mean amplitude, and
the frequency band power spectrum. The “ECoG index,” the ratio of the
spectral power of slow and fast bands (delta+theta/betal+beta2), was also
calculated (19). As for evoked activity, 50 potentials of each modality were
averaged, and latency, duration, and amplitude of the main waves were
measured manually on the screen. Functioning of the peripheral nervous
system was tested on the tail verve. From the data, relative and absolute
refractory period was calculated. All electrophysiological stimulation and
recording of the activities was performed by a PC-based system (Neu-
rosys, Experimetria Ltd, UK).
Just after the electrophysiological recordings, the rats were killed with
an overdose of urethane. The brain, thymus, spleen, kidney, lung, heart,
and liver were removed and weighed for the calculation of relative tissue
weights. The brain samples were stored at –20°C until assay day for the
metal determination.
Determination of Aluminum
In the whole study, deionized and distilled water was used for wash-
ing, dilutions, and standard preparations. An 1000-ppm certified Al atomic
absorption standard solution (Sigma) was used to prepare working stan-
dards. The standard solutions of Al were prepared in 1% nitric acid at var-
ious concentrations such as 0.0, 15.0, 30.0, 45.0, and 60.0 ng/mL. All
standard solutions were prepared daily. Determinations of Al were per-
formed by means of a Varian 30/40 atomic absorption spectrophotometer,
a Varian GTA 96 graphite tube atomizer, and a Varian DS-15 data station.
The graphite furnace was purged with prepurified argon gas during oper-
ation. The “gas stop” condition was used only during the atomization
step. A Varian auto-sampler was used to inject 10-µL aliquots of the sam-
ple solution. Pyrolytically coated graphite tubes (inner diameter, 5.8 mm;
outer diameter, 80 mm; length, 28.0 mm) were used. The mixtures were
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transferred to the sampler of the graphite furnace and the results were
taken from the printer after starting the furnace program. Table 1 shows
the instrument parameters and furnace program for Al measurements.
The detection limit was 1 ng/mL. The analytical linear range was
between 5 and 80 ng/mL. Accuracy was determined by using a certified
standard solution. The recovery was 95%.
Each whole-brain sample was digested with a 6 : 1 mixture of nitric
acid (65%, Merck) and hydrogen peroxide (30%, Merck) in a high-per-
formance microwave digestion unit (Milestone MLS-1200 MEGA) before
the determination of Al. The microwave oven parameters are shown in
Table 2. After that, each sample was diluted with distilled water in the
proper ratio and put into the auto-sampler of the atomic absorption spec-
trophotometer unit.
The principles of the Ethical Committee for the Protection of Animals
in Research of the University were strictly followed during the whole
study.
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Table 1
Instrument Parameters and Furnace Programs 
for Aluminum Determination
Statistical Analysis
The Kolmogorov–Smirnov test was used first to check the normality of
the data. Behavioral effects were analyzed by multivariate analysis of vari-
ance (ANOVA) following square root transformation of the data by a 3×3
(time×doses) design for equal cell content or by nonparametric Kruskal–
Wallis ANOVA. The electrophysiological and Al analysis data were analyzed
by one-way ANOVA. The LSD test was used for a post hoc analysis of group
differences. A probability level of p<0.05 was accepted as significant.
RESULTS
During the treatment period, no visible abnormal sign was observed
in any group. Both treatment dosages (200 mg/kg and 50 mg/kg) caused
considerable decrease in body weight gain of the Al-exposed groups
(p<0.05; see Fig. 1). This was observed from the first week of treatment on
and lasted throughout the study.
Figures 2 and 3 show the open-field and acoustic startle response find-
ings, respectively. Al affected none of the behavioral parameters measured
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Table 2
Microwave Oven Parameters for Tissue Digestion
AU:
Pls spell out 
LSD
at first use.
Fig. 1. Changes in body weights of the groups during the experiment
(mean±SD).
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Fig. 2. Open-field findings in all groups. Group I: control; group II: Al, 50
mg/kg/d; group III: Al, 200 mg/kg/d. (Data are presented as mean±SEM, n=10.)
Fig. 3. Acoustic startle response findings in all groups. Group I: control;
group II: Al, 50 mg/kg/d; group III: Al, 200 mg/kg/d. (Data are presented as
mean±SEM, n=10.)
at either dose levels. No significant difference among the study groups
was observed in horizontal and vertical motor activities and in the startle
responses on treatment wk 2 or wk 8 (p>0.05).
The changes of latency and duration of the sensory-evoked potentials
were treatment dependent. In case of the somatosensory-evoked poten-
tials, the latency of the waves increased in the treated groups. There were
significant differences among the study groups in lengthening of the
latency of the N1 and N2 waves (F[2,27]=4.012, p=0.030; F[2,27]=3.828,
p=0.034, respectively; see Fig. 4A). The interpeak durations also became
longer, but the differences were not significant (p>0.05). In case of the
visual-evoked potential, the latency of waves decreased. Although there
was a significant difference in the latency of N1 (F[2,26]=4.662, p=0.019; see
Fig. 2B), the difference in the latency of N2 was not significant (p>0.05; see
Fig. 4B). Longer interpeak durations were seen in all treated groups, but
the changes were not significant (p>0.05).
There were similar trends of change of the ECoG power spectra. The
fast-wave bands (beta1 and beta2) were decreased to a small extent in the
Al-exposed groups, but the differences among the all study groups were
not significant (p>0.05). The delta band was increased, whereas the other
slow-wave band, theta, was decreased in all treatment groups, but none of
these group-to-group differences was significant (p>0.05). The other
parameters such as amplitude, frequency, and index of ECoGs revealed no
significant differences (p>0.05).
The conduction velocity of the tail nerve was decreased in the treated
groups, but the differences between the groups were insignificant (p>0.05).
The relative and absolute refractory periods were also not significantly
longer. No significant differences of corresponding parameters from dif-
ferent groups were found (p>0.05).
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Fig. 4. Changes of the latency of certain evoked potential waves (A:
somatosensory, B: visual).
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There was no effect of Al treatment on the whole-brain weights
(p>0.05). To calculate relative organ weights, the weight of organs of an
animal was divided by the whole-brain weight of the same animal. Table
3 shows relative organ weights of all groups. Adrenal glands relative
weights were significantly altered in group III (p<0.05 vs control group),
but there were no statistically significant differences among the groups in
thymus, spleen, kidney, lung, heart, and liver weights (p>0.05).
The aluminum content of the whole brain has been determined. The
results were given as micrograms of Al per gram of wet weight of the tis-
sue (µg/g, mean±SD). Whole-brain Al levels of groups I, II, and III were
0.717±0.208, 0.963±0.491, and 1.816±1.157 µg/g, respectively [F(2,27)=6.150,
p=0.0063]. The results are shown in Fig. 5.
DISCUSSION
There are many investigations about Al neurotoxicity and its behav-
ioral toxicity in some experimental animals (11,14,15,18,20–27). It is well
known, however, that the neurotoxic effects of Al in experimental animals
are controversial because the possible harmful effects could be dependent
on the route of administration of Al, type of Al salt, and species of animal.
Despite the known Al neurotoxicty in common laboratory animals, it can-
not be assumed that all species, including humans, are equally susceptible.
The rat and rhesus macaque, for example, appear to be less susceptible to
the toxic effects of Al than are cat, rabbit, mouse, and guinea pig
(3,6,9,11,21,28,29). The reasons of the differences according to the species in
Al toxicity are not known.
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Fig. 5. Aluminum contents in whole brain (Al µg/g wet weight, mean±SD).
AU: ok?
The present study was performed to evaluate Al brain accumulation
and also certain behavioral and electrophysiological effects of the metal in
rats. The doses of Al were calculated as one-fifth and one-twentieth of its
oral LD50 (3,16) and applied by gavage for 8 wk. Al did not affect body
weight and relative organ weights except adrenal glands. However,
weight gain in both treated groups was slower than in the controls over the
treatment period. Decreased weight gain rate may indicate an untoward
effect of Al on general health status. This situation might have resulted
from interference of Al with the hormonal status and/or protein synthesis.
It is noteworthy that adult rats were used in the present study. Our obser-
vation pointed out that a similar experiment should be designed in new-
born rats to clear up whether there is any untoward effects of Al on growth
and whether it is a developmental toxic agent. The dose-related relative
weight change of adrenal glands may have originated from interactions of
Al with, most probably, the immune system or renal system. In order to
answer clearly, further investigations are needed on these points.
Aluminum did not induce gross signs of neurotoxity (paralysis,
seizures). Several parameters of the behavioral tests, including horizontal
and vertical activities and startle responses, remained unaffected by Al
during the test period, and the group means were quite similar. It has been
suggested that the clinical symptoms and localization of Al in the brain
most probably cause alteration of catecholamine balance. Moreover, the
effects of elevated brain Al upon the endogenous steady-stage levels of
norepinephrine and dopamine in the frontal cortex, hippocampus, and
cerebellum have been reported (30). Even though the relation between
dopamine and behavior is clearly known, there was not any change in
behavioral findings in the present study. This situation might have origi-
nated from the insufficient duration of the treatment.
We observed slight changes in electrophysiological parameters such as
ECoGs, but the total results did not confirm the differences in electrophysi-
ological findings. Similarly, Al hydroxide-treated dogs have been shown
that considerable high Al content, whereas the electroencephalogram (EEG)
results were normal (18). In our early study, we showed that AlCl3, depend-
ing on the duration of treatment, produced an impairment of the motor
coordination ability in mice (15). Additionally, Cutrufo et al. showed that a
single oral dose of Al hydroxide in mice induces some slow-wave EEG alter-
ations and produces an increase in the Al level of the brain, depending on
the dose. This finding may suggest the possible role of low-level Al ions in
generation of encephalopathy without any morphological changes in neu-
rons (20). The discrepancies of the studies may be the result of the species of
the animal used, the experiment period, and Al doses applied.
In the study, the rats treated with both the low and high doses had sig-
nificantly higher Al levels in brains than those of the control group. The
present result showed that the ingestion of subchronic Al caused consider-
able accumulation in brain, even though rats are accepted as less susceptible
to Al. Our previous study was indicated that the brain, bone, and kidney Al
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levels of mice fed with Al compounds were significantly greater than in the
control group (13). Similar results have been also observed in many other
investigations in different experimental animals (16,18,23,24,27).
Aluminum may cause or contribute to some specific diseases. It is a
toxicant indeed; the increased tissue burdens can be presumed to impair
biological functions, including those of the CNS. It is proposed that cellu-
lar nuclei may be an important target of potential Al accumulation because
of the high density of phosphates in RNA and DNA. This accumulation
leads most likely to various untoward effects of Al by affecting important
biochemical pathways, including enzymes. It is known that Al has a very
high affinity to phosphate groups; thus, it may interact with phosphate-
containing molecules and enzymes in the body (4,6,10,16,17,24,26,29).
In conclusion, further but chronic studies are apparently needed to
answers these subtle points; also, results should be supported by deter-
mining some biochemical parameters that play key roles in the brain bio-
chemistry in various species, including rats, at various dosage levels and
for various exposure times.
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